Lawmakers, clinicians and patient advocates used an October 2 public hearing to ask the New Mexico Department of Health to ease several entry requirements in its proposed medical psilocybin rules, according to Psychedelic State(s) of America reporting published by Marijuana Moment. The draft rule, 7.35.3 NMAC, would set patient enrollment, provider certification and healing-center standards for the program created by the 2025 Medical Psilocybin Act, which the department aims to open to patients by the end of 2026.
As proposed, patients would need sign-off from a certifying clinician who holds a state controlled-substance number, based on an in-person exam within the previous six months, and the department would decide applications within 30 days. Sessions held on property the patient or provider does not own would need the owner’s written acknowledgment. Sen. Jeff Steinborn, the law’s primary sponsor, opposed the landlord requirement and urged a shorter review period, while advocates proposed letting any licensed provider confirm a qualifying condition.
Several clinicians praised the draft’s training and supervision standards. The rule is not yet final: a hearing officer will submit a recommendation before the department decides whether to adopt it.

